Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly Income from Non-Controlling Interests came in at -$153000.0 in Q2 2026, down 828.57% year-over-year from $21000.0 in Q2 2025, and down 950.0% quarter-over-quarter from $18000.0 in Q1 2026.
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed Income from Non-Controlling Interests across 6 years of filings, most recently posting -$153000.0 for Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests fell 828.57% year-over-year to -$153000.0; the TTM figure through Jun 2026 stood at -$136000.0 (down 1600.0% YoY), while the FY2025 annual figure was $42000.0, up 140.78% from the prior year.
- Income from Non-Controlling Interests came in at -$153000.0 for Q2 2026 at Adaptive Biotechnologies, down from $18000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $22000.0 in Q1 2025 to a low of -$153000.0 in Q2 2026.
- Average Income from Non-Controlling Interests over 5 years is -$25117.6, with a median of -$26000.0 recorded in 2023.
- Year-over-year, Income from Non-Controlling Interests slumped 2500.0% in 2024 and surged 184.62% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at -$41000.0 in 2022, then jumped by 36.59% to -$26000.0 in 2023, then rose by 3.85% to -$25000.0 in 2024, then surged by 96.0% to -$1000.0 in 2025, then slumped by 15200.0% to -$153000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$153000.0 in Q2 2026, $18000.0 in Q1 2026, and -$1000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 14.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 400,000.00 |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -153,000.00 |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -153,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | -25,000.00 |
| Sep 30, 2024 | -26,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -41,000.00 |
| Sep 30, 2022 | -38,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -60,000.00 |
| Dec 31, 2021 | 76,000.00 |
| Sep 30, 2021 | -95,000.00 |